Correlation Between Cogent Biosciences and Viridian Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cogent Biosciences and Viridian Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cogent Biosciences and Viridian Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cogent Biosciences and Viridian Therapeutics, you can compare the effects of market volatilities on Cogent Biosciences and Viridian Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cogent Biosciences with a short position of Viridian Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cogent Biosciences and Viridian Therapeutics.
Diversification Opportunities for Cogent Biosciences and Viridian Therapeutics
0.28 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Cogent and Viridian is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Cogent Biosciences and Viridian Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viridian Therapeutics and Cogent Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cogent Biosciences are associated (or correlated) with Viridian Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viridian Therapeutics has no effect on the direction of Cogent Biosciences i.e., Cogent Biosciences and Viridian Therapeutics go up and down completely randomly.
Pair Corralation between Cogent Biosciences and Viridian Therapeutics
Given the investment horizon of 90 days Cogent Biosciences is expected to under-perform the Viridian Therapeutics. In addition to that, Cogent Biosciences is 1.16 times more volatile than Viridian Therapeutics. It trades about -0.24 of its total potential returns per unit of risk. Viridian Therapeutics is currently generating about -0.1 per unit of volatility. If you would invest 2,328 in Viridian Therapeutics on August 28, 2024 and sell it today you would lose (225.00) from holding Viridian Therapeutics or give up 9.66% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 95.45% |
| Values | Daily Returns |
Cogent Biosciences vs. Viridian Therapeutics
Performance |
| Timeline |
| Cogent Biosciences |
| Viridian Therapeutics |
Cogent Biosciences and Viridian Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cogent Biosciences and Viridian Therapeutics
The main advantage of trading using opposite Cogent Biosciences and Viridian Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cogent Biosciences position performs unexpectedly, Viridian Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viridian Therapeutics will offset losses from the drop in Viridian Therapeutics' long position.| Cogent Biosciences vs. Larimar Therapeutics | Cogent Biosciences vs. Kura Oncology | Cogent Biosciences vs. Kiniksa Pharmaceuticals | Cogent Biosciences vs. Ideaya Biosciences |
| Viridian Therapeutics vs. Eliem Therapeutics | Viridian Therapeutics vs. HCW Biologics | Viridian Therapeutics vs. Scpharmaceuticals | Viridian Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |